nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabilone—CNR2—pancreatic cancer	0.481	0.579	CbGaD
Nabilone—CNR1—pancreatic cancer	0.35	0.421	CbGaD
Nabilone—Dronabinol—CNR2—pancreatic cancer	0.00377	0.579	CrCbGaD
Nabilone—Dronabinol—CNR1—pancreatic cancer	0.00274	0.421	CrCbGaD
Nabilone—CNR2—Signaling by GPCR—SSTR1—pancreatic cancer	0.000264	0.00336	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CNR1—pancreatic cancer	0.000261	0.00331	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PPY—pancreatic cancer	0.000259	0.00329	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—SHH—pancreatic cancer	0.000256	0.00325	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SSTR2—pancreatic cancer	0.000255	0.00323	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PRLHR—pancreatic cancer	0.000255	0.00323	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—IAPP—pancreatic cancer	0.000252	0.00321	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—GCG—pancreatic cancer	0.000252	0.0032	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000247	0.00314	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCKBR—pancreatic cancer	0.000246	0.00312	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000242	0.00308	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000242	0.00308	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—AGTR1—pancreatic cancer	0.00024	0.00305	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000238	0.00303	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GDI1—pancreatic cancer	0.000233	0.00296	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GDI2—pancreatic cancer	0.000233	0.00296	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GAST—pancreatic cancer	0.000233	0.00296	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000229	0.0029	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PPY—pancreatic cancer	0.000224	0.00285	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—SST—pancreatic cancer	0.000222	0.00281	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—SCT—pancreatic cancer	0.000221	0.0028	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.00022	0.00279	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000216	0.00275	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000212	0.0027	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GAST—pancreatic cancer	0.000211	0.00269	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCK—pancreatic cancer	0.000211	0.00267	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000208	0.00264	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000205	0.00261	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PPY—pancreatic cancer	0.000204	0.00259	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CASP3—pancreatic cancer	0.000202	0.00257	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000202	0.00256	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SCT—pancreatic cancer	0.0002	0.00255	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SSTR2—pancreatic cancer	0.0002	0.00254	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—GCG—pancreatic cancer	0.000197	0.00251	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—CTNNB1—pancreatic cancer	0.000195	0.00247	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000193	0.00245	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PRLHR—pancreatic cancer	0.000192	0.00243	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCK—pancreatic cancer	0.000191	0.00243	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000188	0.00239	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GLP1R—pancreatic cancer	0.000186	0.00237	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CCKAR—pancreatic cancer	0.000183	0.00233	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GAST—pancreatic cancer	0.000183	0.00232	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—IAPP—pancreatic cancer	0.000182	0.00231	CbGpPWpGaD
Nabilone—CNR2—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000182	0.00231	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ZNRF3—pancreatic cancer	0.00018	0.00229	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—ACVR1B—pancreatic cancer	0.00018	0.00229	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—SRC—pancreatic cancer	0.000176	0.00223	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000174	0.00222	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—SCT—pancreatic cancer	0.000173	0.0022	CbGpPWpGaD
Nabilone—CNR1—BDNF signaling pathway—STAT3—pancreatic cancer	0.00017	0.00216	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SHH—pancreatic cancer	0.000167	0.00212	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GAST—pancreatic cancer	0.000166	0.00211	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCK—pancreatic cancer	0.000165	0.0021	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—IAPP—pancreatic cancer	0.000165	0.0021	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SSTR3—pancreatic cancer	0.000163	0.00207	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DTX1—pancreatic cancer	0.000163	0.00207	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000161	0.00205	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000161	0.00205	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—SST—pancreatic cancer	0.00016	0.00203	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTHLH—pancreatic cancer	0.000158	0.00201	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PTCH1—pancreatic cancer	0.000158	0.00201	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000158	0.00201	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SCT—pancreatic cancer	0.000157	0.002	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SSTR1—pancreatic cancer	0.000156	0.00198	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PPY—pancreatic cancer	0.000153	0.00195	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SSTR2—pancreatic cancer	0.00015	0.00191	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PRLHR—pancreatic cancer	0.00015	0.00191	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCK—pancreatic cancer	0.00015	0.00191	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—CNR1—pancreatic cancer	0.000147	0.00187	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000146	0.00186	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CNR2—pancreatic cancer	0.000146	0.00186	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCKBR—pancreatic cancer	0.000145	0.00185	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—SST—pancreatic cancer	0.000145	0.00184	CbGpPWpGaD
Nabilone—CNR2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000144	0.00184	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000144	0.00183	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000143	0.00181	CbGpPWpGaD
Nabilone—CNR1—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000143	0.00181	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—GCG—pancreatic cancer	0.000142	0.00181	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000141	0.0018	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000141	0.0018	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000137	0.00174	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—GLI1—pancreatic cancer	0.000137	0.00173	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—DTX4—pancreatic cancer	0.000137	0.00173	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000136	0.00172	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—CNR1—pancreatic cancer	0.000134	0.0017	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000133	0.00169	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRP1—pancreatic cancer	0.000133	0.00169	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—SHH—pancreatic cancer	0.000131	0.00167	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—IAPP—pancreatic cancer	0.00013	0.00165	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—GCG—pancreatic cancer	0.000129	0.00164	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HEY2—pancreatic cancer	0.000128	0.00162	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—DTX1—pancreatic cancer	0.000128	0.00162	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SSTR3—pancreatic cancer	0.000128	0.00162	CbGpPWpGaD
Nabilone—Headache—Erlotinib—pancreatic cancer	0.000127	0.00151	CcSEcCtD
Nabilone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Nabilone—Chills—Docetaxel—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Nabilone—Asthenia—Sunitinib—pancreatic cancer	0.000126	0.0015	CcSEcCtD
Nabilone—Decreased appetite—Irinotecan—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—Arrhythmia—Docetaxel—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—Dyspnoea—Gemcitabine—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—SST—pancreatic cancer	0.000125	0.00159	CbGpPWpGaD
Nabilone—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—Insomnia—Fluorouracil—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GAST—pancreatic cancer	0.000125	0.00159	CbGpPWpGaD
Nabilone—Somnolence—Gemcitabine—pancreatic cancer	0.000125	0.00149	CcSEcCtD
Nabilone—Affect lability—Doxorubicin—pancreatic cancer	0.000125	0.00148	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000124	0.00158	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000124	0.00158	CbGpPWpGaD
Nabilone—Fatigue—Irinotecan—pancreatic cancer	0.000124	0.00148	CcSEcCtD
Nabilone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000124	0.00148	CcSEcCtD
Nabilone—Pruritus—Sunitinib—pancreatic cancer	0.000124	0.00148	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—HRAS—pancreatic cancer	0.000124	0.00157	CbGpPWpGaD
Nabilone—Pain—Irinotecan—pancreatic cancer	0.000123	0.00147	CcSEcCtD
Nabilone—Constipation—Irinotecan—pancreatic cancer	0.000123	0.00147	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—AGTR1—pancreatic cancer	0.000123	0.00157	CbGpPWpGaD
Nabilone—Dyspnoea—Fluorouracil—pancreatic cancer	0.000123	0.00147	CcSEcCtD
Nabilone—Somnolence—Fluorouracil—pancreatic cancer	0.000123	0.00146	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SSTR1—pancreatic cancer	0.000123	0.00156	CbGpPWpGaD
Nabilone—Face oedema—Doxorubicin—pancreatic cancer	0.000122	0.00146	CcSEcCtD
Nabilone—Decreased appetite—Gemcitabine—pancreatic cancer	0.000122	0.00145	CcSEcCtD
Nabilone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000122	0.00145	CcSEcCtD
Nabilone—Nausea—Tamoxifen—pancreatic cancer	0.000121	0.00145	CcSEcCtD
Nabilone—Fatigue—Gemcitabine—pancreatic cancer	0.000121	0.00144	CcSEcCtD
Nabilone—Gastritis—Epirubicin—pancreatic cancer	0.000121	0.00144	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PPY—pancreatic cancer	0.00012	0.00153	CbGpPWpGaD
Nabilone—Constipation—Gemcitabine—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Pain—Gemcitabine—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Nausea—Erlotinib—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Decreased appetite—Fluorouracil—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Mood swings—Doxorubicin—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Diarrhoea—Sunitinib—pancreatic cancer	0.00012	0.00143	CcSEcCtD
Nabilone—Ataxia—Doxorubicin—pancreatic cancer	0.000119	0.00142	CcSEcCtD
Nabilone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000119	0.00142	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SCT—pancreatic cancer	0.000118	0.0015	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HEY1—pancreatic cancer	0.000118	0.0015	CbGpPWpGaD
Nabilone—Back pain—Docetaxel—pancreatic cancer	0.000118	0.00141	CcSEcCtD
Nabilone—Pain—Fluorouracil—pancreatic cancer	0.000118	0.00141	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SSTR2—pancreatic cancer	0.000118	0.0015	CbGpPWpGaD
Nabilone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000118	0.0014	CcSEcCtD
Nabilone—Dizziness—Sunitinib—pancreatic cancer	0.000116	0.00138	CcSEcCtD
Nabilone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000116	0.00138	CcSEcCtD
Nabilone—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.000116	0.00138	CcSEcCtD
Nabilone—Abdominal pain—Irinotecan—pancreatic cancer	0.000114	0.00136	CcSEcCtD
Nabilone—Body temperature increased—Irinotecan—pancreatic cancer	0.000114	0.00136	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCKBR—pancreatic cancer	0.000114	0.00145	CbGpPWpGaD
Nabilone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000114	0.00136	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—SST—pancreatic cancer	0.000114	0.00144	CbGpPWpGaD
Nabilone—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000113	0.00144	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCK—pancreatic cancer	0.000113	0.00143	CbGpPWpGaD
Nabilone—Anaemia—Docetaxel—pancreatic cancer	0.000113	0.00134	CcSEcCtD
Nabilone—Gastritis—Doxorubicin—pancreatic cancer	0.000112	0.00133	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—GCG—pancreatic cancer	0.000112	0.00142	CbGpPWpGaD
Nabilone—Vomiting—Sunitinib—pancreatic cancer	0.000111	0.00133	CcSEcCtD
Nabilone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000111	0.00132	CcSEcCtD
Nabilone—Rash—Sunitinib—pancreatic cancer	0.00011	0.00131	CcSEcCtD
Nabilone—Dermatitis—Sunitinib—pancreatic cancer	0.00011	0.00131	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GLP1R—pancreatic cancer	0.00011	0.0014	CbGpPWpGaD
Nabilone—CNR2—GPCR ligand binding—CXCL8—pancreatic cancer	0.00011	0.0014	CbGpPWpGaD
Nabilone—Headache—Sunitinib—pancreatic cancer	0.00011	0.00131	CcSEcCtD
Nabilone—Syncope—Docetaxel—pancreatic cancer	0.00011	0.0013	CcSEcCtD
Nabilone—CNR1—BDNF signaling pathway—AKT1—pancreatic cancer	0.000109	0.00139	CbGpPWpGaD
Nabilone—Leukopenia—Docetaxel—pancreatic cancer	0.000109	0.0013	CcSEcCtD
Nabilone—Pollakiuria—Epirubicin—pancreatic cancer	0.000109	0.0013	CcSEcCtD
Nabilone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000109	0.0013	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CCKAR—pancreatic cancer	0.000108	0.00138	CbGpPWpGaD
Nabilone—Palpitations—Docetaxel—pancreatic cancer	0.000108	0.00129	CcSEcCtD
Nabilone—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000108	0.00129	CcSEcCtD
Nabilone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000107	0.00128	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—DTX4—pancreatic cancer	0.000107	0.00136	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLI1—pancreatic cancer	0.000107	0.00136	CbGpPWpGaD
Nabilone—Cough—Docetaxel—pancreatic cancer	0.000107	0.00127	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000106	0.00135	CbGpPWpGaD
Nabilone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000106	0.00127	CcSEcCtD
Nabilone—Convulsion—Docetaxel—pancreatic cancer	0.000106	0.00126	CcSEcCtD
Nabilone—Hypertension—Docetaxel—pancreatic cancer	0.000105	0.00126	CcSEcCtD
Nabilone—Drowsiness—Epirubicin—pancreatic cancer	0.000105	0.00126	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—JAG2—pancreatic cancer	0.000105	0.00133	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRP1—pancreatic cancer	0.000104	0.00132	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000104	0.00132	CbGpPWpGaD
Nabilone—Chest pain—Docetaxel—pancreatic cancer	0.000104	0.00124	CcSEcCtD
Nabilone—Myalgia—Docetaxel—pancreatic cancer	0.000104	0.00124	CcSEcCtD
Nabilone—Arthralgia—Docetaxel—pancreatic cancer	0.000104	0.00124	CcSEcCtD
Nabilone—Nausea—Sunitinib—pancreatic cancer	0.000104	0.00124	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—MEN1—pancreatic cancer	0.000103	0.00131	CbGpPWpGaD
Nabilone—Asthenia—Irinotecan—pancreatic cancer	0.000103	0.00123	CcSEcCtD
Nabilone—Stomatitis—Epirubicin—pancreatic cancer	0.000103	0.00122	CcSEcCtD
Nabilone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000102	0.00121	CcSEcCtD
Nabilone—Dry mouth—Docetaxel—pancreatic cancer	0.000102	0.00121	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—GCG—pancreatic cancer	0.000101	0.00129	CbGpPWpGaD
Nabilone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000101	0.0012	CcSEcCtD
Nabilone—Asthenia—Gemcitabine—pancreatic cancer	0.000101	0.0012	CcSEcCtD
Nabilone—Confusional state—Docetaxel—pancreatic cancer	0.0001	0.0012	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HEY2—pancreatic cancer	0.0001	0.00127	CbGpPWpGaD
Nabilone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	9.98e-05	0.00119	CcSEcCtD
Nabilone—Epistaxis—Epirubicin—pancreatic cancer	9.94e-05	0.00118	CcSEcCtD
Nabilone—Pruritus—Gemcitabine—pancreatic cancer	9.94e-05	0.00118	CcSEcCtD
Nabilone—Infection—Docetaxel—pancreatic cancer	9.9e-05	0.00118	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SHH—pancreatic cancer	9.87e-05	0.00125	CbGpPWpGaD
Nabilone—Diarrhoea—Irinotecan—pancreatic cancer	9.86e-05	0.00118	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NOTCH4—pancreatic cancer	9.81e-05	0.00125	CbGpPWpGaD
Nabilone—Shock—Docetaxel—pancreatic cancer	9.81e-05	0.00117	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GAST—pancreatic cancer	9.8e-05	0.00125	CbGpPWpGaD
Nabilone—Pruritus—Fluorouracil—pancreatic cancer	9.77e-05	0.00116	CcSEcCtD
Nabilone—Drowsiness—Doxorubicin—pancreatic cancer	9.75e-05	0.00116	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—IAPP—pancreatic cancer	9.75e-05	0.00124	CbGpPWpGaD
Nabilone—Tachycardia—Docetaxel—pancreatic cancer	9.73e-05	0.00116	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—AGTR1—pancreatic cancer	9.67e-05	0.00123	CbGpPWpGaD
Nabilone—Diarrhoea—Gemcitabine—pancreatic cancer	9.61e-05	0.00114	CcSEcCtD
Nabilone—Dizziness—Irinotecan—pancreatic cancer	9.53e-05	0.00114	CcSEcCtD
Nabilone—Stomatitis—Doxorubicin—pancreatic cancer	9.51e-05	0.00113	CcSEcCtD
Nabilone—Anorexia—Docetaxel—pancreatic cancer	9.5e-05	0.00113	CcSEcCtD
Nabilone—Diarrhoea—Fluorouracil—pancreatic cancer	9.45e-05	0.00113	CcSEcCtD
Nabilone—Hypoaesthesia—Epirubicin—pancreatic cancer	9.41e-05	0.00112	CcSEcCtD
Nabilone—Pharyngitis—Epirubicin—pancreatic cancer	9.39e-05	0.00112	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PTHLH—pancreatic cancer	9.36e-05	0.00119	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTCH1—pancreatic cancer	9.36e-05	0.00119	CbGpPWpGaD
Nabilone—Hypotension—Docetaxel—pancreatic cancer	9.31e-05	0.00111	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SCT—pancreatic cancer	9.29e-05	0.00118	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HEY1—pancreatic cancer	9.29e-05	0.00118	CbGpPWpGaD
Nabilone—Epistaxis—Doxorubicin—pancreatic cancer	9.2e-05	0.0011	CcSEcCtD
Nabilone—Vomiting—Irinotecan—pancreatic cancer	9.17e-05	0.00109	CcSEcCtD
Nabilone—Dizziness—Fluorouracil—pancreatic cancer	9.13e-05	0.00109	CcSEcCtD
Nabilone—Visual impairment—Epirubicin—pancreatic cancer	9.12e-05	0.00109	CcSEcCtD
Nabilone—Rash—Irinotecan—pancreatic cancer	9.09e-05	0.00108	CcSEcCtD
Nabilone—Dermatitis—Irinotecan—pancreatic cancer	9.08e-05	0.00108	CcSEcCtD
Nabilone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	9.08e-05	0.00108	CcSEcCtD
Nabilone—Headache—Irinotecan—pancreatic cancer	9.03e-05	0.00108	CcSEcCtD
Nabilone—Insomnia—Docetaxel—pancreatic cancer	9.01e-05	0.00107	CcSEcCtD
Nabilone—Paraesthesia—Docetaxel—pancreatic cancer	8.95e-05	0.00107	CcSEcCtD
Nabilone—Vomiting—Gemcitabine—pancreatic cancer	8.93e-05	0.00106	CcSEcCtD
Nabilone—Dyspnoea—Docetaxel—pancreatic cancer	8.89e-05	0.00106	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCK—pancreatic cancer	8.86e-05	0.00113	CbGpPWpGaD
Nabilone—Somnolence—Docetaxel—pancreatic cancer	8.86e-05	0.00106	CcSEcCtD
Nabilone—Rash—Gemcitabine—pancreatic cancer	8.86e-05	0.00105	CcSEcCtD
Nabilone—Dermatitis—Gemcitabine—pancreatic cancer	8.85e-05	0.00105	CcSEcCtD
Nabilone—Eye disorder—Epirubicin—pancreatic cancer	8.84e-05	0.00105	CcSEcCtD
Nabilone—Tinnitus—Epirubicin—pancreatic cancer	8.82e-05	0.00105	CcSEcCtD
Nabilone—Headache—Gemcitabine—pancreatic cancer	8.8e-05	0.00105	CcSEcCtD
Nabilone—Flushing—Epirubicin—pancreatic cancer	8.78e-05	0.00105	CcSEcCtD
Nabilone—Vomiting—Fluorouracil—pancreatic cancer	8.78e-05	0.00105	CcSEcCtD
Nabilone—Dyspepsia—Docetaxel—pancreatic cancer	8.77e-05	0.00105	CcSEcCtD
Nabilone—Hypoaesthesia—Doxorubicin—pancreatic cancer	8.71e-05	0.00104	CcSEcCtD
Nabilone—Rash—Fluorouracil—pancreatic cancer	8.71e-05	0.00104	CcSEcCtD
Nabilone—Dermatitis—Fluorouracil—pancreatic cancer	8.7e-05	0.00104	CcSEcCtD
Nabilone—Pharyngitis—Doxorubicin—pancreatic cancer	8.69e-05	0.00104	CcSEcCtD
Nabilone—Decreased appetite—Docetaxel—pancreatic cancer	8.66e-05	0.00103	CcSEcCtD
Nabilone—Headache—Fluorouracil—pancreatic cancer	8.65e-05	0.00103	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CNR2—pancreatic cancer	8.64e-05	0.0011	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—GLP1R—pancreatic cancer	8.64e-05	0.0011	CbGpPWpGaD
Nabilone—CNR1—GPCR ligand binding—CXCL8—pancreatic cancer	8.63e-05	0.0011	CbGpPWpGaD
Nabilone—Fatigue—Docetaxel—pancreatic cancer	8.59e-05	0.00102	CcSEcCtD
Nabilone—Nausea—Irinotecan—pancreatic cancer	8.56e-05	0.00102	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SST—pancreatic cancer	8.56e-05	0.00109	CbGpPWpGaD
Nabilone—Pain—Docetaxel—pancreatic cancer	8.52e-05	0.00102	CcSEcCtD
Nabilone—Constipation—Docetaxel—pancreatic cancer	8.52e-05	0.00102	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—CCKAR—pancreatic cancer	8.5e-05	0.00108	CbGpPWpGaD
Nabilone—Chills—Epirubicin—pancreatic cancer	8.49e-05	0.00101	CcSEcCtD
Nabilone—Arrhythmia—Epirubicin—pancreatic cancer	8.45e-05	0.00101	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.44e-05	0.00107	CbGpPWpGaD
Nabilone—Visual impairment—Doxorubicin—pancreatic cancer	8.44e-05	0.00101	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—JAG1—pancreatic cancer	8.38e-05	0.00106	CbGpPWpGaD
Nabilone—Nausea—Gemcitabine—pancreatic cancer	8.34e-05	0.000994	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NOTCH3—pancreatic cancer	8.34e-05	0.00106	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—JAG2—pancreatic cancer	8.24e-05	0.00105	CbGpPWpGaD
Nabilone—Feeling abnormal—Docetaxel—pancreatic cancer	8.21e-05	0.000978	CcSEcCtD
Nabilone—Nausea—Fluorouracil—pancreatic cancer	8.2e-05	0.000977	CcSEcCtD
Nabilone—Eye disorder—Doxorubicin—pancreatic cancer	8.18e-05	0.000975	CcSEcCtD
Nabilone—Tinnitus—Doxorubicin—pancreatic cancer	8.16e-05	0.000972	CcSEcCtD
Nabilone—Gastrointestinal pain—Docetaxel—pancreatic cancer	8.15e-05	0.000971	CcSEcCtD
Nabilone—Flushing—Doxorubicin—pancreatic cancer	8.13e-05	0.000968	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—MEN1—pancreatic cancer	8.12e-05	0.00103	CbGpPWpGaD
Nabilone—Tension—Epirubicin—pancreatic cancer	8.08e-05	0.000963	CcSEcCtD
Nabilone—Nervousness—Epirubicin—pancreatic cancer	8e-05	0.000953	CcSEcCtD
Nabilone—Back pain—Epirubicin—pancreatic cancer	7.97e-05	0.000949	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—CNR1—pancreatic cancer	7.9e-05	0.001	CbGpPWpGaD
Nabilone—Body temperature increased—Docetaxel—pancreatic cancer	7.88e-05	0.000939	CcSEcCtD
Nabilone—Abdominal pain—Docetaxel—pancreatic cancer	7.88e-05	0.000939	CcSEcCtD
Nabilone—Chills—Doxorubicin—pancreatic cancer	7.86e-05	0.000936	CcSEcCtD
Nabilone—Arrhythmia—Doxorubicin—pancreatic cancer	7.82e-05	0.000932	CcSEcCtD
Nabilone—Vision blurred—Epirubicin—pancreatic cancer	7.76e-05	0.000925	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SHH—pancreatic cancer	7.75e-05	0.000984	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH4—pancreatic cancer	7.7e-05	0.000978	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CG—pancreatic cancer	7.67e-05	0.000974	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—IAPP—pancreatic cancer	7.65e-05	0.000972	CbGpPWpGaD
Nabilone—Ill-defined disorder—Epirubicin—pancreatic cancer	7.64e-05	0.00091	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—GCG—pancreatic cancer	7.63e-05	0.000969	CbGpPWpGaD
Nabilone—Anaemia—Epirubicin—pancreatic cancer	7.61e-05	0.000907	CcSEcCtD
Nabilone—Agitation—Epirubicin—pancreatic cancer	7.57e-05	0.000902	CcSEcCtD
Nabilone—Tension—Doxorubicin—pancreatic cancer	7.48e-05	0.000891	CcSEcCtD
Nabilone—Malaise—Epirubicin—pancreatic cancer	7.43e-05	0.000885	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.42e-05	0.000943	CbGpPWpGaD
Nabilone—Nervousness—Doxorubicin—pancreatic cancer	7.4e-05	0.000882	CcSEcCtD
Nabilone—Vertigo—Epirubicin—pancreatic cancer	7.4e-05	0.000882	CcSEcCtD
Nabilone—Syncope—Epirubicin—pancreatic cancer	7.39e-05	0.00088	CcSEcCtD
Nabilone—Leukopenia—Epirubicin—pancreatic cancer	7.37e-05	0.000878	CcSEcCtD
Nabilone—Back pain—Doxorubicin—pancreatic cancer	7.37e-05	0.000878	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—PTHLH—pancreatic cancer	7.34e-05	0.000933	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTCH1—pancreatic cancer	7.34e-05	0.000933	CbGpPWpGaD
Nabilone—Hypersensitivity—Docetaxel—pancreatic cancer	7.34e-05	0.000875	CcSEcCtD
Nabilone—Palpitations—Epirubicin—pancreatic cancer	7.28e-05	0.000867	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—AGTR1—pancreatic cancer	7.28e-05	0.000925	CbGpPWpGaD
Nabilone—Loss of consciousness—Epirubicin—pancreatic cancer	7.24e-05	0.000862	CcSEcCtD
Nabilone—Cough—Epirubicin—pancreatic cancer	7.19e-05	0.000856	CcSEcCtD
Nabilone—Vision blurred—Doxorubicin—pancreatic cancer	7.18e-05	0.000856	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—STK11—pancreatic cancer	7.17e-05	0.000911	CbGpPWpGaD
Nabilone—Asthenia—Docetaxel—pancreatic cancer	7.15e-05	0.000852	CcSEcCtD
Nabilone—Convulsion—Epirubicin—pancreatic cancer	7.14e-05	0.00085	CcSEcCtD
Nabilone—Hypertension—Epirubicin—pancreatic cancer	7.11e-05	0.000847	CcSEcCtD
Nabilone—Ill-defined disorder—Doxorubicin—pancreatic cancer	7.07e-05	0.000842	CcSEcCtD
Nabilone—Pruritus—Docetaxel—pancreatic cancer	7.05e-05	0.00084	CcSEcCtD
Nabilone—Anaemia—Doxorubicin—pancreatic cancer	7.04e-05	0.000839	CcSEcCtD
Nabilone—Arthralgia—Epirubicin—pancreatic cancer	7.01e-05	0.000835	CcSEcCtD
Nabilone—Myalgia—Epirubicin—pancreatic cancer	7.01e-05	0.000835	CcSEcCtD
Nabilone—Chest pain—Epirubicin—pancreatic cancer	7.01e-05	0.000835	CcSEcCtD
Nabilone—Agitation—Doxorubicin—pancreatic cancer	7e-05	0.000834	CcSEcCtD
Nabilone—Anxiety—Epirubicin—pancreatic cancer	6.99e-05	0.000833	CcSEcCtD
Nabilone—Discomfort—Epirubicin—pancreatic cancer	6.93e-05	0.000825	CcSEcCtD
Nabilone—Malaise—Doxorubicin—pancreatic cancer	6.87e-05	0.000819	CcSEcCtD
Nabilone—Dry mouth—Epirubicin—pancreatic cancer	6.86e-05	0.000817	CcSEcCtD
Nabilone—Vertigo—Doxorubicin—pancreatic cancer	6.85e-05	0.000816	CcSEcCtD
Nabilone—Syncope—Doxorubicin—pancreatic cancer	6.83e-05	0.000814	CcSEcCtD
Nabilone—Leukopenia—Doxorubicin—pancreatic cancer	6.82e-05	0.000813	CcSEcCtD
Nabilone—Diarrhoea—Docetaxel—pancreatic cancer	6.82e-05	0.000812	CcSEcCtD
Nabilone—Confusional state—Epirubicin—pancreatic cancer	6.78e-05	0.000807	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CD—pancreatic cancer	6.74e-05	0.000856	CbGpPWpGaD
Nabilone—Palpitations—Doxorubicin—pancreatic cancer	6.74e-05	0.000802	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SST—pancreatic cancer	6.72e-05	0.000853	CbGpPWpGaD
Nabilone—Loss of consciousness—Doxorubicin—pancreatic cancer	6.7e-05	0.000798	CcSEcCtD
Nabilone—Infection—Epirubicin—pancreatic cancer	6.68e-05	0.000796	CcSEcCtD
Nabilone—Cough—Doxorubicin—pancreatic cancer	6.65e-05	0.000792	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CG—pancreatic cancer	6.62e-05	0.000842	CbGpPWpGaD
Nabilone—Shock—Epirubicin—pancreatic cancer	6.61e-05	0.000788	CcSEcCtD
Nabilone—Convulsion—Doxorubicin—pancreatic cancer	6.6e-05	0.000787	CcSEcCtD
Nabilone—Dizziness—Docetaxel—pancreatic cancer	6.59e-05	0.000785	CcSEcCtD
Nabilone—Hypertension—Doxorubicin—pancreatic cancer	6.58e-05	0.000784	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—JAG1—pancreatic cancer	6.57e-05	0.000835	CbGpPWpGaD
Nabilone—Tachycardia—Epirubicin—pancreatic cancer	6.56e-05	0.000782	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NOTCH3—pancreatic cancer	6.55e-05	0.000832	CbGpPWpGaD
Nabilone—Hyperhidrosis—Epirubicin—pancreatic cancer	6.5e-05	0.000774	CcSEcCtD
Nabilone—Arthralgia—Doxorubicin—pancreatic cancer	6.49e-05	0.000773	CcSEcCtD
Nabilone—Myalgia—Doxorubicin—pancreatic cancer	6.49e-05	0.000773	CcSEcCtD
Nabilone—Chest pain—Doxorubicin—pancreatic cancer	6.49e-05	0.000773	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.47e-05	0.000822	CbGpPWpGaD
Nabilone—Anxiety—Doxorubicin—pancreatic cancer	6.47e-05	0.00077	CcSEcCtD
Nabilone—Discomfort—Doxorubicin—pancreatic cancer	6.41e-05	0.000764	CcSEcCtD
Nabilone—Anorexia—Epirubicin—pancreatic cancer	6.41e-05	0.000763	CcSEcCtD
Nabilone—Dry mouth—Doxorubicin—pancreatic cancer	6.35e-05	0.000756	CcSEcCtD
Nabilone—Vomiting—Docetaxel—pancreatic cancer	6.34e-05	0.000755	CcSEcCtD
Nabilone—Rash—Docetaxel—pancreatic cancer	6.28e-05	0.000749	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—SMAD4—pancreatic cancer	6.28e-05	0.000798	CbGpPWpGaD
Nabilone—Hypotension—Epirubicin—pancreatic cancer	6.28e-05	0.000748	CcSEcCtD
Nabilone—Dermatitis—Docetaxel—pancreatic cancer	6.28e-05	0.000748	CcSEcCtD
Nabilone—Confusional state—Doxorubicin—pancreatic cancer	6.27e-05	0.000747	CcSEcCtD
Nabilone—Headache—Docetaxel—pancreatic cancer	6.24e-05	0.000744	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—CXCL8—pancreatic cancer	6.22e-05	0.00079	CbGpPWpGaD
Nabilone—Infection—Doxorubicin—pancreatic cancer	6.18e-05	0.000736	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—HES1—pancreatic cancer	6.13e-05	0.000779	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	6.12e-05	0.00073	CcSEcCtD
Nabilone—Shock—Doxorubicin—pancreatic cancer	6.12e-05	0.000729	CcSEcCtD
Nabilone—Insomnia—Epirubicin—pancreatic cancer	6.08e-05	0.000724	CcSEcCtD
Nabilone—Tachycardia—Doxorubicin—pancreatic cancer	6.07e-05	0.000723	CcSEcCtD
Nabilone—Paraesthesia—Epirubicin—pancreatic cancer	6.04e-05	0.000719	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CG—pancreatic cancer	6.02e-05	0.000764	CbGpPWpGaD
Nabilone—Hyperhidrosis—Doxorubicin—pancreatic cancer	6.01e-05	0.000716	CcSEcCtD
Nabilone—Dyspnoea—Epirubicin—pancreatic cancer	5.99e-05	0.000714	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—GCG—pancreatic cancer	5.99e-05	0.000761	CbGpPWpGaD
Nabilone—Somnolence—Epirubicin—pancreatic cancer	5.98e-05	0.000712	CcSEcCtD
Nabilone—Anorexia—Doxorubicin—pancreatic cancer	5.93e-05	0.000706	CcSEcCtD
Nabilone—Nausea—Docetaxel—pancreatic cancer	5.92e-05	0.000705	CcSEcCtD
Nabilone—Dyspepsia—Epirubicin—pancreatic cancer	5.92e-05	0.000705	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—PIK3CB—pancreatic cancer	5.87e-05	0.000746	CbGpPWpGaD
Nabilone—Decreased appetite—Epirubicin—pancreatic cancer	5.84e-05	0.000696	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CD—pancreatic cancer	5.82e-05	0.00074	CbGpPWpGaD
Nabilone—Hypotension—Doxorubicin—pancreatic cancer	5.81e-05	0.000692	CcSEcCtD
Nabilone—Fatigue—Epirubicin—pancreatic cancer	5.8e-05	0.00069	CcSEcCtD
Nabilone—Constipation—Epirubicin—pancreatic cancer	5.75e-05	0.000685	CcSEcCtD
Nabilone—Pain—Epirubicin—pancreatic cancer	5.75e-05	0.000685	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—AGTR1—pancreatic cancer	5.71e-05	0.000726	CbGpPWpGaD
Nabilone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	5.67e-05	0.000675	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—CXCL8—pancreatic cancer	5.65e-05	0.000717	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STK11—pancreatic cancer	5.63e-05	0.000715	CbGpPWpGaD
Nabilone—Insomnia—Doxorubicin—pancreatic cancer	5.63e-05	0.00067	CcSEcCtD
Nabilone—Paraesthesia—Doxorubicin—pancreatic cancer	5.59e-05	0.000665	CcSEcCtD
Nabilone—Dyspnoea—Doxorubicin—pancreatic cancer	5.55e-05	0.000661	CcSEcCtD
Nabilone—Feeling abnormal—Epirubicin—pancreatic cancer	5.54e-05	0.00066	CcSEcCtD
Nabilone—Somnolence—Doxorubicin—pancreatic cancer	5.53e-05	0.000659	CcSEcCtD
Nabilone—Gastrointestinal pain—Epirubicin—pancreatic cancer	5.5e-05	0.000655	CcSEcCtD
Nabilone—Dyspepsia—Doxorubicin—pancreatic cancer	5.48e-05	0.000652	CcSEcCtD
Nabilone—Decreased appetite—Doxorubicin—pancreatic cancer	5.41e-05	0.000644	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—TERT—pancreatic cancer	5.38e-05	0.000683	CbGpPWpGaD
Nabilone—Fatigue—Doxorubicin—pancreatic cancer	5.36e-05	0.000639	CcSEcCtD
Nabilone—Constipation—Doxorubicin—pancreatic cancer	5.32e-05	0.000634	CcSEcCtD
Nabilone—Pain—Doxorubicin—pancreatic cancer	5.32e-05	0.000634	CcSEcCtD
Nabilone—Abdominal pain—Epirubicin—pancreatic cancer	5.31e-05	0.000633	CcSEcCtD
Nabilone—Body temperature increased—Epirubicin—pancreatic cancer	5.31e-05	0.000633	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—PIK3CD—pancreatic cancer	5.29e-05	0.000672	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HIF1A—pancreatic cancer	5.14e-05	0.000653	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TSC2—pancreatic cancer	5.13e-05	0.000652	CbGpPWpGaD
Nabilone—Feeling abnormal—Doxorubicin—pancreatic cancer	5.13e-05	0.000611	CcSEcCtD
Nabilone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	5.09e-05	0.000606	CcSEcCtD
Nabilone—CNR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	5.08e-05	0.000645	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—APOE—pancreatic cancer	5.02e-05	0.000638	CbGpPWpGaD
Nabilone—Hypersensitivity—Epirubicin—pancreatic cancer	4.95e-05	0.00059	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—SMAD4—pancreatic cancer	4.93e-05	0.000626	CbGpPWpGaD
Nabilone—Abdominal pain—Doxorubicin—pancreatic cancer	4.92e-05	0.000586	CcSEcCtD
Nabilone—Body temperature increased—Doxorubicin—pancreatic cancer	4.92e-05	0.000586	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—KDR—pancreatic cancer	4.92e-05	0.000625	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—CXCL8—pancreatic cancer	4.88e-05	0.00062	CbGpPWpGaD
Nabilone—Asthenia—Epirubicin—pancreatic cancer	4.82e-05	0.000575	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HES1—pancreatic cancer	4.81e-05	0.000612	CbGpPWpGaD
Nabilone—Pruritus—Epirubicin—pancreatic cancer	4.76e-05	0.000567	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—NFKBIA—pancreatic cancer	4.68e-05	0.000594	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NOTCH1—pancreatic cancer	4.63e-05	0.000588	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CB—pancreatic cancer	4.61e-05	0.000586	CbGpPWpGaD
Nabilone—Diarrhoea—Epirubicin—pancreatic cancer	4.6e-05	0.000548	CcSEcCtD
Nabilone—Hypersensitivity—Doxorubicin—pancreatic cancer	4.58e-05	0.000546	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3CG—pancreatic cancer	4.53e-05	0.000575	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—NRAS—pancreatic cancer	4.53e-05	0.000575	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGF—pancreatic cancer	4.48e-05	0.000569	CbGpPWpGaD
Nabilone—Asthenia—Doxorubicin—pancreatic cancer	4.46e-05	0.000532	CcSEcCtD
Nabilone—Dizziness—Epirubicin—pancreatic cancer	4.45e-05	0.00053	CcSEcCtD
Nabilone—CNR1—Signaling by GPCR—CXCL8—pancreatic cancer	4.43e-05	0.000563	CbGpPWpGaD
Nabilone—Pruritus—Doxorubicin—pancreatic cancer	4.4e-05	0.000524	CcSEcCtD
Nabilone—Vomiting—Epirubicin—pancreatic cancer	4.27e-05	0.000509	CcSEcCtD
Nabilone—Diarrhoea—Doxorubicin—pancreatic cancer	4.26e-05	0.000507	CcSEcCtD
Nabilone—Rash—Epirubicin—pancreatic cancer	4.24e-05	0.000505	CcSEcCtD
Nabilone—Dermatitis—Epirubicin—pancreatic cancer	4.23e-05	0.000504	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—TERT—pancreatic cancer	4.22e-05	0.000536	CbGpPWpGaD
Nabilone—Headache—Epirubicin—pancreatic cancer	4.21e-05	0.000502	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—EGFR—pancreatic cancer	4.13e-05	0.000524	CbGpPWpGaD
Nabilone—Dizziness—Doxorubicin—pancreatic cancer	4.11e-05	0.00049	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—HIF1A—pancreatic cancer	4.03e-05	0.000513	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TSC2—pancreatic cancer	4.02e-05	0.000511	CbGpPWpGaD
Nabilone—Nausea—Epirubicin—pancreatic cancer	3.99e-05	0.000476	CcSEcCtD
Nabilone—CNR2—Signaling Pathways—PIK3CD—pancreatic cancer	3.98e-05	0.000506	CbGpPWpGaD
Nabilone—Vomiting—Doxorubicin—pancreatic cancer	3.95e-05	0.000471	CcSEcCtD
Nabilone—CNR2—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.94e-05	0.000501	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—APOE—pancreatic cancer	3.94e-05	0.0005	CbGpPWpGaD
Nabilone—Rash—Doxorubicin—pancreatic cancer	3.92e-05	0.000467	CcSEcCtD
Nabilone—Dermatitis—Doxorubicin—pancreatic cancer	3.92e-05	0.000467	CcSEcCtD
Nabilone—CNR2—Signaling by GPCR—KRAS—pancreatic cancer	3.9e-05	0.000495	CbGpPWpGaD
Nabilone—Headache—Doxorubicin—pancreatic cancer	3.9e-05	0.000464	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—KDR—pancreatic cancer	3.86e-05	0.00049	CbGpPWpGaD
Nabilone—Nausea—Doxorubicin—pancreatic cancer	3.69e-05	0.00044	CcSEcCtD
Nabilone—CNR1—Signaling Pathways—NFKBIA—pancreatic cancer	3.67e-05	0.000466	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NOTCH1—pancreatic cancer	3.63e-05	0.000462	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—PIK3CA—pancreatic cancer	3.58e-05	0.000455	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CG—pancreatic cancer	3.55e-05	0.000452	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—NRAS—pancreatic cancer	3.55e-05	0.000452	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGF—pancreatic cancer	3.51e-05	0.000446	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CB—pancreatic cancer	3.47e-05	0.000441	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CXCL8—pancreatic cancer	3.33e-05	0.000424	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—HRAS—pancreatic cancer	3.31e-05	0.000421	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—EGFR—pancreatic cancer	3.24e-05	0.000411	CbGpPWpGaD
Nabilone—CNR2—GPCR downstream signaling—AKT1—pancreatic cancer	3.22e-05	0.000409	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CASP3—pancreatic cancer	3.19e-05	0.000406	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CD—pancreatic cancer	3.12e-05	0.000397	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CCND1—pancreatic cancer	3.11e-05	0.000395	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.09e-05	0.000393	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—CTNNB1—pancreatic cancer	3.08e-05	0.000391	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—KRAS—pancreatic cancer	3.06e-05	0.000389	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MMP9—pancreatic cancer	3.02e-05	0.000383	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PTEN—pancreatic cancer	3e-05	0.000381	CbGpPWpGaD
Nabilone—CNR2—Signaling by GPCR—AKT1—pancreatic cancer	2.93e-05	0.000372	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—PIK3CA—pancreatic cancer	2.81e-05	0.000357	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—SRC—pancreatic cancer	2.78e-05	0.000353	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CB—pancreatic cancer	2.72e-05	0.000346	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—VEGFA—pancreatic cancer	2.71e-05	0.000344	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—STAT3—pancreatic cancer	2.68e-05	0.000341	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—NRAS—pancreatic cancer	2.68e-05	0.00034	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CXCL8—pancreatic cancer	2.62e-05	0.000332	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—HRAS—pancreatic cancer	2.6e-05	0.00033	CbGpPWpGaD
Nabilone—CNR1—GPCR downstream signaling—AKT1—pancreatic cancer	2.53e-05	0.000321	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CASP3—pancreatic cancer	2.5e-05	0.000318	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—MYC—pancreatic cancer	2.49e-05	0.000317	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TGFB1—pancreatic cancer	2.49e-05	0.000316	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CCND1—pancreatic cancer	2.44e-05	0.00031	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—EGFR—pancreatic cancer	2.44e-05	0.00031	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—CTNNB1—pancreatic cancer	2.41e-05	0.000307	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MMP9—pancreatic cancer	2.37e-05	0.000301	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PTEN—pancreatic cancer	2.35e-05	0.000299	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—KRAS—pancreatic cancer	2.3e-05	0.000293	CbGpPWpGaD
Nabilone—CNR1—Signaling by GPCR—AKT1—pancreatic cancer	2.3e-05	0.000292	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—SRC—pancreatic cancer	2.18e-05	0.000277	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—VEGFA—pancreatic cancer	2.13e-05	0.00027	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—PIK3CA—pancreatic cancer	2.12e-05	0.000269	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—STAT3—pancreatic cancer	2.1e-05	0.000267	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—NRAS—pancreatic cancer	2.1e-05	0.000267	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—TP53—pancreatic cancer	2.05e-05	0.00026	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—HRAS—pancreatic cancer	1.96e-05	0.000249	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—MYC—pancreatic cancer	1.96e-05	0.000248	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TGFB1—pancreatic cancer	1.95e-05	0.000248	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—EGFR—pancreatic cancer	1.91e-05	0.000243	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—KRAS—pancreatic cancer	1.81e-05	0.00023	CbGpPWpGaD
Nabilone—CNR2—Signaling Pathways—AKT1—pancreatic cancer	1.73e-05	0.00022	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.66e-05	0.000211	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—TP53—pancreatic cancer	1.61e-05	0.000204	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—HRAS—pancreatic cancer	1.54e-05	0.000195	CbGpPWpGaD
Nabilone—CNR1—Signaling Pathways—AKT1—pancreatic cancer	1.36e-05	0.000172	CbGpPWpGaD
